Sylvia Cheung, Chief Financial Officer at Anika Therapeutics, Inc. (ANIK), sold 6,310 shares at $49.01 ($310K) on 2017-02-22, disclosed to the SEC on 2017-02-24.
Open-market sale of $310k ANIK by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.01 | 2,000 | $98K | 31.7% |
| 2 | $49.02 | 807 | $40K | 12.8% |
| 3 | $49.05 | 1,193 | $59K | 18.9% |
| 4 | $49.05 | 1,193 | $59K | 18.9% |
| 5 | $49.20 | 1,117 | $55K | 17.8% |
| Total | $49.06 avg | 6,310 |
| $310K |
| 100% |